Antimicrob Agents Chemother
- FRIAES A, Mamede R, Santos B, Marrao G, et al
Increase of macrolide resistance among Streptococcus pyogenes pharyngitis driven
by a mef(A)-msr(D)/emm2-ST55 lineage in Portugal (2014-2019).
Antimicrob Agents Chemother. 2025 Oct 10:e0096825. doi: 10.1128/aac.00968.
Clin Infect Dis
- HAO J, Liu X, Wang D, Hu H, et al
Transmitted Human Immunodeficiency Virus Type 1 (HIV-1) Drug Resistance Among
Newly Diagnosed Individuals in 31 Provincial-Level Administrative Divisions in
China in 2023: A Cross-sectional Survey.
Clin Infect Dis. 2025 Apr 29:ciaf159. doi: 10.1093.
- ROGG L, Underwood M, Hanan N, Castillo-Mancilla JR, et al
Phase 1 Evaluation of VH4524184, a Third-Generation Integrase Strand Transfer
Inhibitor With an Enhanced Resistance Profile.
Clin Infect Dis. 2025 Mar 21:ciaf135. doi: 10.1093.
- CHARPENTIER C, Berzow D, Le Hingrat Q, Kaiser R, et al
HIV-2EU - Supporting Standardized HIV-2 Drug Resistance Interpretation: an
Update.
Clin Infect Dis. 2025 Mar 12:ciaf110. doi: 10.1093.
- DE MIGUEL R, de Lagarde Sebastian M, Blanco Arevalo JL, Pinto-Martinez A, et al
Dolutegravir/Lamivudine for Maintenance of Virological Suppression in Persons
with Historical Suspected or Confirmed Resistance to Lamivudine: Week 48 Results
of a Single-Arm, Open-Label, Multicentre, Phase IIA Clinical Trial.
Clin Infect Dis. 2025 Mar 7:ciaf100. doi: 10.1093.
- CHEMALY RF, Shafat T, Wald A, Kotton CN, et al
Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in
Immunocompromised Patients: Literature Review and Proposed Definitions for Use in
Clinical Trials.
Clin Infect Dis. 2025 Jan 29:ciae638. doi: 10.1093.
- LEE YT, Chen SC
Unveiling Latent Risk Patterns in Antimicrobial-Resistant Bacteremia: A Deeper
Look at Pathogen-Specific Mortality.
Clin Infect Dis. 2025 Oct 10:ciaf493. doi: 10.1093.
Int J Antimicrob Agents
- GAO S, Quan Y, Song S, Jin W, et al
Corrigendum to "Disrupting bacterial metabolism by targeting LDH reverses
Streptococcus suis aminoglycoside resistance" [International Journal of
Antimicrobial Agents 66/6 (2025) 1-16/107599].
Int J Antimicrob Agents. 2025 Oct 9:107631.
- PATEL RR, Arun PP, Singh SK, Singh M, et al
Overcoming Antimicrobial Resistance: Phage Therapy as a Promising Solution to
Combat ESKAPE Pathogens.
Int J Antimicrob Agents. 2025 Oct 8:107640.
- TAI JH, Lyu YY, Zhang YS, Chu WW, et al
Global, Regional, and National Burden of Bacterial Carbapenem Resistance from
1990 to 2021 and Predictions up to 2035.
Int J Antimicrob Agents. 2025 Oct 8:107636.
J Antimicrob Chemother
- LAI CC, Liu CY, Huang KJ, Huang YT, et al
Global susceptibility profiles and potential resistance mechanisms of
ceftazidime-avibactam-resistant, non-carbapenemase-producing carbapenem-resistant
Enterobacterales: 2020-23 data from the Antimicrobial Testing Leadership and
Surveillance.
J Antimicrob Chemother. 2025 Oct 7:dkaf375. doi: 10.1093.
- CHOWDHURY FR, Findlay BL
Sequential antibiotic exposure restores antibiotic susceptibility.
J Antimicrob Chemother. 2025 Oct 8:dkaf350. doi: 10.1093.
J Bacteriol
- ARYA G, Chodisetti PK, Espinosa J, Russo BC, et al
Enterococcus faecium sagA mutants have cell envelope defects influencing
antibiotic resistance and bacteriophage susceptibility.
J Bacteriol. 2025 Oct 9:e0030225. doi: 10.1128/jb.00302.
- GJENNESTAD RS, Heggenhougen MV, Ruud Winther A, Moldstad J, et al
The effect of MurM and a branched cell wall structure on penicillin resistance in
Streptococcus pneumoniae.
J Bacteriol. 2025 Oct 8:e0014125. doi: 10.1128/jb.00141.
J Clin Microbiol
- YUKAWA K, Harada S, Komori K, Hayama B, et al
Corynebacterium striatum infections in oncologic patients: clinical spectrum,
resistance profiles, and evidence of nosocomial transmission.
J Clin Microbiol. 2025;63:e0082925.
- ARMSTRONG DT, Baird ECE, Pretty L, D'Agostino K, et al
Diagnostics and new treatment regimens for TB: can the Xpert MTB/XDR assay fill
the gap for fluoroquinolone testing?
J Clin Microbiol. 2025;63:e0064325.
Nature
- KAVANAGH K
The rise of 'nightmare bacteria': antimicrobial resistance in five charts.
Nature. 2025 Oct 7. doi: 10.1038/d41586-025-03218.
PLoS One
- GOBEZIE MY, Hassen M, Solomon T, Demessie MB, et al
Carriage rates and antimicrobial resistance of Staphylococcus aureus and
methicillin-resistant Staphylococcus aureus in Ethiopia: A systematic review and
meta-analysis.
PLoS One. 2025;20:e0333054.
- SHRESTHA P, Tandukar S, Shrestha M, Shrestha S, et al
Bacteriophage as an anti-biofilm agent against Pseudomonas aeruginosa from wound
infection.
PLoS One. 2025;20:e0334139.
- BRUINS MJ, Eijkelkamp-Biesterbos L, Meutstege AM, Dos Santos CO, et al
Escherichia coli antimicrobial resistance in acute urinary tract infection lower
than reported in Dutch national surveillance database.
PLoS One. 2025;20:e0334222.
- CUMMINGS CL, Landreville KD, Kuzma J
Public perceptions and support for introduced microbes to combat
hospital-acquired infections and antimicrobial resistance.
PLoS One. 2025;20:e0332578.
- MENGISTU AB, Belete MA, Tassew H, Kassa HY, et al
Multidrug-resistant non-typhoidal Salmonella enterica from chickens, farmworkers,
and environments: One health implications from Northwestern Ethiopia.
PLoS One. 2025;20:e0333591.
- YOSEF HL, Yohannes M, Diriba R, Legese MH, et al
Multidrug-resistant bacterial profiles of inanimate objects at Zewditu Memorial
Hospital, Addis Ababa, Ethiopia.
PLoS One. 2025;20:e0333361.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016